GSTP1 and osteosarcoma: Our data showed the polymorphism of GSTP1 appears to be independent prognostic factors in osteosarcoma patients receiving chemotherapy, and GSTM1 and GSTT1 polymorphisms have no statistically significant association with osteosarcoma patients.